Rebecca Hartman, MD, MPH, Michelle Henry, MD, and Patty Pophal are the newest members of The Melanoma Research Foundation (MRF)’s Board of Directors.
Rebecca Hartman, MD, MPH, is affiliated with the Dana Farber Cancer Institute (“DFCI”) in Boston, MA and the VA Boston Healthcare System (“VABHS”). She has been actively involved with the MRF’s Scientific Advisory Committee (SAC) and the Dermatology Alliance Council (DAC). She received a Career Development Award for her research on the “Impact of Covid-19 on Melanoma Patients”.
Michelle Henry, MD, FAAD, is the CEO and founder of Skin & Aesthetic Surgery of Manhattan and the founder of The Henry Research Group. Dr. Henry also serves as a Clinical Instructor of Dermatology at Weill Cornell Medical College.
She was critical in helping establish the MRF’s Skin of Color Institute. In 2022, the MRF was honored to recognize Dr. Henry at the 21st Annual New York Gala with the Excellence in Prevention and to have her leadership as a Gala Co-Chair for 2023 and 2024’s events.
Patty Pophalis is a Senior Accountant at KMSH, an accounting firm in Beachwood, Ohio. She has been involved with the MRF since 2017. Her daughter, Grace, was diagnosed in 2015 with Stage IV melanoma and sadly passed on July 7, 2023. Patty continues her involvement with the MRF as chair of the Cleveland Miles for Melanoma 5k run/walk event, additionally helping to make connections within the medical community in Cleveland.
(Read their full bios here.)
